
Kenvue Inc.
KVUE
KVUE: Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
moreShow KVUE Financials
Recent trades of KVUE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by KVUE's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on KVUE's company Twitter account
Number of mentions of KVUE in WallStreetBets Daily Discussion
Recent insights relating to KVUE
Recent picks made for KVUE stock on CNBC
ETFs with the largest estimated holdings in KVUE
Flights by private jets registered to KVUE